Geographic disparities in cervical cancer mortality: What are the roles of risk factor prevalence, screening, and use of recommended treatment?

Journal of Rural Health

Volumn 21, Issue 2, 2005, Pages 149-157

  Yabroff, K Robin ^a,b   Lawrence, William F ^b,c   King, Jason C ^d   Mangan, Patricia ^e   Washington, Kathleen Shakira ^b   Yi, Bin ^b   Kerner, Jon F ^a   Mandelblatt, Jeanne S ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

^d GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CONTROL; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SCREENING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MORTALITY; PAPANICOLAOU TEST; POPULATION RISK; PREVALENCE; REVIEW; RISK FACTOR; RURAL POPULATION; SEXUAL BEHAVIOR; UNITED STATES; UTERINE CERVIX CANCER; WART VIRUS;

EID: 16244411636     PISSN: 0890765X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1748-0361.2005.tb00075.x     Document Type: Review

References (123)

1. Ries LAG, Kosary CL, Hankey BF, Edwards BK. SEER Cancer Statistic Review, 1973-1996. Bethesda, Md: National Cancer Institute; 1999.
2. Kim K, Rigal RD, Patrick JR, et al. The changing trends of uterine cancer and cytology: a study of morbidity and mortality trends over a twenty year period. Cancer. 1978;42:2439-2449.
3. Christopherson WM, Lundin FE, Mendez WM, Parker JE. Cervical cancer control: a study of morbidity and mortality trends over a twenty-one-year period. Cancer. 1976;38:1357-1366.
4. Dunn JE Jr, Schweitzer V. The relationship of cervical cytology to the incidence of invasive cervical cancer and mortality in Alameda County, California, 1960 to 1974. Am J Obstet Gynecol. 1981;139:868-876.
5. Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R. Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst. 2001;93:1704-1713.
6. Blackman DK, Bennett EM, Miller DS. Trends in self-reported use of mammograms (1989-997) and Papanicolaou tests (1991-997)-Behavioral Risk Factor Surveillance System. Morbid Mortal Wkly Rep CDC Surveill Summ. 1999;48:1-22.
7. Devesa SS, Grauman DG, Blot WJ, Pennello G, Hoover RN, Fraumeni JF Jr. Atlas of Cancer Mortality in the United States, 1950-94. Washington, DC: US Government Print Office; 1999.
8. Hall HI, Rogers JD, Weir HK, Miller DS, Uhler RJ. Breast and cervical carcinoma mortality among women in the Appalachian region of the U.S., 1976-1996. Cancer. 2000;89:1593-1602.
9. Hartmann KE, Nanda K, Hall S, Myers E. Technologic advances for evaluation of cervical cytology: is newer better? Obstet Gynecol Surv. 2001;56:765-774.
10. Risk for cervical disease in HIV-infected women - New York City. MMWR Morbid Mortal Wkly Rep. 1990;39:846-849.
11. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ. 1994;309:1286-1291.
12. Monroe AC, Ricketts TC, Savitz LA. Cancer in rural versus urban populations: a review. J Rural Health. 1992;8:212-220.
13. Sawaya GF, Brown AD, Washington AE, Garber AM. Current approaches to cervical-cancer screening. N Engl J Med. 2001;344:1603-1607.
14. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94:334-357.
15. Harris R, Leininger L. Preventive care in rural primary care practice. Cancer. 1993;72(3 Suppl):1113-1118.
16. Hart LG, Salsberg E, Phillips DM, Lishner DM. Rural health care providers in the United States. J Rural Health. 2003;18:211-232.
17. Hawkins R, Curtiss C. Cancer resources for providers in the rural community. Cancer Pract. 1997;5:383-386.
18. Yabroff KR. American Hospital Association data review. Reducing Health Disparities in High Cervical Cancer Mortality Regions Meeting, The National Cancer Institute; Corpus Christi, Tex.; 2001.
19. Moscovice IS. Rural hospitals: a literature synthesis and health services research agenda. Health Serv Res. 1989;23:892-930.
20. Ramsbottom-Lucier M, Emmett K, Rich EC, Wilson JF. Hills, ridges, mountains, and roads: geographical factors and access to care in rural Kentucky. J Rural Health. 1996;12:386-394.
21. Sawyer JA, Earp J, Fletcher RH, Daye FF, Wynn TM. Pap tests of rural black women. J Gen Intern Med. 1990;5:115-119.
22. Guidry JJ, Aday LA, Zhang D, Winn RJ. Transportation as a barrier to cancer treatment. Cancer Pract. 1997;5:361-366.
23. Goodwin JS, Hunt WC, Samet JM. Determinants of cancer therapy in elderly patients. Cancer. 1993;72:594-601.
24. Dignan M, Michielutte R, Sharp P, Bahnson J, Young L, Beal P. The role of focus groups in health education for cervical cancer among minority women. J Community Health. 1990;15:369-375.
25. Peters RK, Thomas D, Hagan DG, Mack TM, Henderson BE. Risk factors for invasive cervical cancer among Latinas and non-Latinas in Los Angeles county. J Natl Cancer Inst. 1986;77:1063-1077.
26. Ferrante JM, Gonzalez EC, Roetzheim RG, Pal N, Woodard L. Clinical and demographic predictors of late-stage cervical cancer. Arch Fam Med. 2000;9:439-445.
27. Howe SL, Delfino RJ, Taylor TH, Anton-Culver H. The risk of invasive cervical cancer among Hispanics: evidence for targeted preventive interventions. Prev Med. 1998;27(5 Pt 1):674-680.
28. Mitchell JB, McCormack LA. Time trends in late-stage diagnosis of cervical cancer. Differences by race/ethnicity and income. Med Care. 1997;35:1220-1224.
29. DesHarnais S. The National Cancer Database: Review of issues related to access to care and treatment patterns. Reducing Health Disparities in High Cervical Cancer Mortality Regions Meeting, The National Cancer Institute; Corpus Christi, Tex; 2001.
30. Trimble E, Harlan LC. Exploring SEER Treatment Data. Reducing Health Disparities in High Cervical Cancer Mortality Regions Meeting, The National Cancer Institute; Corpus Christi, Tex; 2001.
31. Rowland D, Lyons B. Triple jeopardy: Rural, poor, and uninsured. Health Serv Res. 1989;23:975-1004.
32. Vernon SD, Unger ER, Piper MA, et al. HIV and human papillomavirus as independent risk factors for cervical neoplasia in women with high or low numbers of sex partners. Sex Transm Infect. 1999;75:258-260.
33. Cerqueira EM, Santoro CL, Donozo NF, et al. Genetic damage in exfoliated cells of the uterine cervix. Association and interaction between cigarette smoking and progression to malignant transformation? Acta Cytol. 1998;42:639-649.
34. Schiffman MH. New epidemiology of human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst. 1995;87:1345-1347.
35. Butterworth CE Jr, Hatch KD, Macaluso M, et al. Folate deficiency and cervical dysplasia. JAMA. 1992;267:528-533.
36. Kjellberg L, Hallmans G, Ahren AM, et al. Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection. Br J Cancer. 2000;82:1332-1338.
37. Fasal E, Simmons ME, Kampert JB. Factors associated with high and low risk of cervical neoplasia. J Natl Cancer Inst. 1981;66:631-636.
38. Ho GY, Kadish AS, Burk RD, et al. HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia. Int J Cancer. 1998;78:281-285.
39. Ursin G, Pike MC, Preston-Martin S, d'Ablaing G III, Peters RK. Sexual, reproductive, and other risk factors for adenocarcinoma of the cervix: results from a population-based case-control study (California, United States). Cancer Causes Control. 1996;7:391-401.
40. Hisada M, van den Berg BJ, Strickler HD, et al. Prospective study of antibody to human papilloma virus type 16 and risk of cervical, endometrial, and ovarian cancers (United States). Cancer Causes Control. 2001;12:335-341.
41. Lepine LA, Hilllis SD, Marchbanks PA, et al. Hysterectomy surveillance-United States, 1980-1993. Morbid Mortal Wkly Rep CDC Surveill Summ. 1997;46:1-15.
42. Giuliano AR, Papenfuss M, Abrahamsen M, et al. Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control. Cancer Epidemiol Biomarkers Prev. 2001;10:1129-1136.
43. Coker AL, Jenkins GR, Busnardo MS, Chambers JC, Levine LZ, Pirisi L. Human papillomaviruses and cervical neoplasia in South Carolina. Cancer Epidemiol Biomarkers Prev. 1993;2:207-212.
44. Cartwright PS, Dao AH, Reed GW. Human papillomavirus in women. A three-year experience in a county hospital colposcopy clinic. J Reprod Med. 1992;37:167-169.
45. Aral SO, Soskoline V, Joesoef RM, O'Reilly KR. Sex partner recruitment as risk factor for STD: clustering of risky modes. Sex Transm Dis. 1991;18:10-17.
46. Wiesenfeld HC, Lowry DL, Heine RP, et al. Self-collection of vaginal swabs for the detection of Chlamydia, gonorrhea, and trichomoniasis: opportunity to encourage sexually transmitted disease testing among adolescents. Sex Transm Dis. 2001;28:321-325.
47. Omar H, Callahan P, Aggarwal S, Perkins K, Young K. Cervical pathology in West Virginia adolescents. W V Med J. 2000;96:408-409.
48. Jubelirer SJ, Blanton MF, Blanton PD, et al. Assessment of knowledge, attitudes, and behaviors relative to cervical cancer and the Pap smear among adolescent girls in West Virginia. J Cancer Educ. 1996;11:230-232.
49. Nagy S, Watts GF, Nagy MC. Coital status and perceptions about sexual abstinence refusal skills. J Adolesc Health. 2002;31:79-83.
50. Durbin M, DiClemente RJ, Siegel D, Krasnovsky F, Lazarus N, Camacho T. Factors associated with multiple sex partners among junior high school students. J Adolesc Health. 1993;14:202-207.
51. Willems JP, Saunders JT, Hunt DE, Schorling JB. Prevalence of coronary heart disease risk factors among rural blacks: a community base study. South Med J. 1997;90:814-820.
52. Greenlund KJ, Kiefe CI, Gidding SS, et al. Difference in cardiovascular disease risk factors in black and white young adults: comparisons among five communities of the CARDIA and the Bogalusa heart studies. Ann Epidemiol. 1998;8:22-30.
53. Gilliland FD, Mahler R, Davis SM. Non-ceremonial tobacco use among southwestern rural American Indians: the New Mexico American Indian Behavioural Risk Factor Survey. Tob Control. 1998;7:156-160.
54. Vitolins MZ, Quandt SA, Case LD, Bell RA, Arcury TA, McDonald J. Vitamin and mineral supplement use by older rural adults. J Gerontol A Biol Sci Med Sci. 2000;55:M613-M617.
55. Marshall TA, Stumbo PJ, Warren JJ, Xie XJ. Inadequate nutrient intakes are common and are associated with low diet variety in rural, community-dwelling elderly. J Nutr. 2001;131:2192-2196.
56. Hildesheim A, Hadjimichael O, Schwartz PE, et al. Risk factors for rapid-onset cervical cancer. Am J Obstet Gynecol. 1999;180(3 Pt 1):571-577.
57. Holmquist ND. Revisiting the effect of the Pap test on cervical cancer. Am J Pub Health. 2000;90:620-623.
58. Sung HY, Kearney KA, Miller M, Kinney W, Sawaya GF, Hiatt RA. Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan. Cancer. 2000;88:2283-2289.
59. Hall HI, Uhler RJ, Coughlin SS, Miller DS. Breast and cervical cancer screening among Appalachian women. Cancer Epidemiol Biomarkers Prev. 2002;11:137-142.
60. Hewitt M, Devesa S, Breen N. Papanicolaou test use among reproductive-age women at high risk for cervical cancer: analysis of the 1995 National Survey of Family Growth. Am J Public Health. 2002;92:666-669.
61. Elnicki DM, Morris DK, Shockcor WT. Patient-perceived barriers to preventive health care among indigent, rural Appalachian patients. Arch Intern Med. 1995;155:421-424.
62. Austin RM, Baron PL, Gates CE. Opportunities for enhanced cervical and breast screening referral in Charleston County. J S C Med Assoc. 1993;89:323-328.
63. Gilliland FD, Mahler R, Hunt WC, Davis SM. Preventive health care among rural American Indians in New Mexico. Prev Med. 1999;28:194-202.
64. McPhee SJ, Bird JA, Davis T, Ha NT, Jenkins CN, Le B. Barriers to breast and cervical cancer screening among Vietnamese-American women. Am J Prev Med. 1997;13:205-213.
65. Stearns SC, Slifkin RT, Edin HM. Access to care for rural Medicare beneficiaries. J Rural Health. 2000;16:31-42.
66. Ramirez AG, Suarez L, Laufman L, Barroso C, Chalela P. Hispanic women's breast and cervical cancer knowledge, attitudes, and screening behaviors. Am J Health Promot. 2000;14:292-299.
67. Coughlin SS, Thompson TD, Hall HI, Logan P, Uhler RJ. Breast and cervical carcinoma screening practices among women in rural and nonrural areas of the United States, 1998-1999. Cancer. 2002;94:2801-2812.
68. Chavez LR, Hubbell FA, Mishra SI, Valdez RB. The influence of fatalism on self-reported use of Papanicolaou smears. Am J Prev Med. 1997;13:418-424.
69. Casey MM, Call KT, Klingner JM. Are rural residents less likely to obtain recommended preventive healthcare services? Am J Prev Med. 2001;21:182-188.
70. Frank-Stromborg M, Wassner LJ, Nelson M, Chilton B, Wholeben BE. A study of rural Latino women seeking cancer-detection examinations. J Cancer Educ. 1998;13:231-241.
71. Hiatt RA, Pasick RJ, Stewart S, et al. Community-based cancer screening for underserved women: design and baseline findings from the Breast and Cervical Cancer Intervention Study. Prev Med. 2001;33:190-203.
72. Lantz PM, Weigers ME, House JS. Education and income differentials in breast and cervical cancer screening. Policy implications for rural women. Med Care. 1997;35:219-236.
73. Strickland J, Strickland DL. Barriers to preventive health services for minority households in the rural South. J Rural Health. 1996;12:206-217.
74. Suarez L, Roche RA, Nichols D, Simpson DM. Knowledge, behavior, and fears concerning breast and cervical cancer among older low-income Mexican-American women. Am J Prev Med. 1997;13:137-142.
75. Castellano PZ, Wenger NK, Graves WL. Adherence to screening guidelines for breast and cervical cancer in postmenopausal women with coronary heart disease: an ancillary study of volunteers for hers. J Womens Health Gend Based Med. 2001;10:451-461.
76. Gulitz E, Bustillo-Hernandez M, Kent EB. Missed cancer screening opportunities among older women: a provider survey. Cancer Pract. 1998;6:325-332.
77. Bloom JR, Stewart SL, Koo J, Hiatt RA. Cancer screening in public health clinics: the importance of clinic utilization. Med Care. 2001;39:1345-1351.
78. Oleszkowicz KL, Kresch GM, Painter JT. Pap smear screening in family physicians' offices in a rural area with a high cervical cancer rate. Fam Med. 1994;26:648-650.
79. Schootman M, Fuortes LJ. Breast and cervical carcinoma: the correlation of activity limitations and rurality with screening, disease incidence, and mortality. Cancer. 1999;86:1087-1094.
80. Hueston WJ, Hubbard ET. Preventive services for rural and urban African American adults. Arch Fam Med. 2000;9:263-266.
81. Muldoon JT, Schootman M, Morton RF. Utilization of cancer early detection services among farm and rural nonfarm adults in Iowa. J Rural Health. 1996;12:321-331.
82. Zhang P, Tao G, Irwin KL. Utilization of preventive medical services in the United States: a comparison between rural and urban populations. J Rural Health. 2000;16:349-356.
83. Duelberg SI. Preventive health behavior among black and white women in urban and rural areas. Soc Sci Med. 1992;34:191-198.
84. US Census Bureau. U.S. Census Bureau American Community Survey. Available at: www.census.gov/acs/www. 2003.
85. Paskett ED, Tatum CM, Mack DW, Hoen H, Case LD, Velez R. Validation of self-reported breast and cervical cancer screening tests among low-income minority women. Cancer Epidemiol Biomarkers Prev. 1996;5:721-726.
86. Suarez L, Goldman DA, Weiss NS. Validity of Pap smear and mammogram self-reports in a low-income Hispanic population. Am J Prev Med. 1995;11:94-98.
87. Nanda K, McCrory DC, Myers ER, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med. 2000;132:810-819.
88. Ratman S, Franco EL, Ferenczy A. Human papillomavirus testing for primary screening of cervical cancer precursors. Cancer Epidemiol Biomarkers Prev. 2000;9:945-951.
89. Curtis P, Mintzer M, Morrell D, Resnick JC, Hendrix S, Qaqish BF. Characteristics and quality of Papanicolaou smears obtained by primary care clinicians using a single commercial laboratory. Arch Fam Med. 1999;8:407-413.
90. Fiscella K, Franks P. The adequacy of Papanicolaou smears as performed by family physicians and obstetrician-gynecologists. J Fam Pract. 1999;48:294-298.
91. Traczyk JM, Johnson SG, Komaniecki TF, et al. CLIA's impact on the availability of laboratory services. Chicago, Ill: Regional Office of Inspector General, Dept of Health and Human Services; 1995. OEI-5-4-0130, i-C-4.
92. Davey-Sullivan BJ, Gearhart JG. The use of the Pap smear in Mississippi. J Miss State Med Assoc. 1991;32:167-71.
93. Curtis P, Morrell D, Hendrix S, Mintzer M, Resnick JC, Qaqish BF. Recall and treatment decisions of primary care providers in response to Pap smear reports. Am J Prev Med. 1997;13:427-431.
94. Fox P, Amsberger P, Zhang X. An examination of differential follow-up rates in cervical cancer screening. J Community Health. 1997;22:199-209.
95. Melnikow J, Chan BK, Stewart GK. Do follow-up recommendations for abnormal Papanicolaou smears influence patient adherence? Arch Fam Med. 1999;8:510-514.
96. Paskett ED, Carter WB, Chu J, White E. Compliance behavior in women with abnormal Pap smears: developing and testing a decision model. Med Care. 1990;28:643-656.
97. McKee MD, Lurio J, Marantz P, Burton W, Mulvihill M. Barriers to follow-up of abnormal Papanicolaou smears in an urban community health center. Arch Fam Med. 1999;8:129-134.
98. del Carmen MG, Montz FJ, Bristow RE, Bovicelli A, Cornelison T, Trimble E. Ethnic differences in patterns of care of stage 1A1 and 1A2 cervical cancer: a SEER database study. Gynecol Oncol. 1999;75:113-117.
99. Spitler HD, Mayo RM, Parker VG. Patterns of breast, cervical, colorectal, and prostate cancer in the Appalachian region of South Carolina. Ethn Dis. 2001;11:51-59.
100. Gilliland FD, Hunt WC, Key CR. Trends in the survival of American Indian, Hispanic, and non-Hispanic White cancer patients in New Mexico and Arizona, 1969-1994. Cancer. 1998;82:1769-1783.
101. Schootman M, Myers-Geadelmann J, Fuortes L. Factors associated with adequacy of diagnostic workup after abnormal breast cancer screening results. J Am Board Fam Pract. 2000;13:94-100.
102. Liff JM, Chow WH, Greenberg RS. Rural-urban differences in stage at diagnosis: possible relationship to cancer screening. Cancer. 1991;67:1454-1459.
103. Greenberg RS, Chow WH, Liff JM. Recent trends in the epidemiology of cervical neoplasia. Acta Cytol 1989;33:463-470.
104. Friedell GH, Tucker TC, McManmon E, Moser M, Hernandez C, Nadel M. Incidence of dysplasia and carcinoma of the uterine cervix in an Appalachian population. J Natl Cancer Inst. 1992;84:1030-1032.
105. Saikaly HH, Martin D, Traylor L. Evaluation of a cytologic cervical cancer screening program. J Ky Med Assoc. 1987;85:75-77.
106. Mount SL, Papillo JL. A study of 10,296 pediatric and adolescent Papanicolaou smear diagnoses in northern New England. Pediatrics. 1999;103:539-545.
107. Weiss HL, Soong SJ, Partridge EE, Carpenetr J, Bryant B, Waterbor JW. Cancer incidence among predominantly black, rural-poor populations in southern states. South Med J. 1997;90:986-992.
108. Greenberg RS, Stevens JA, Whitaker JP. Cancer incidence rates among blacks in urban and rural Georgia. Am J Public Health. 1985;75:683-684.
109. Sung JF, Blumenthal DS, Alema-Mensah E, McGrady GA. Racial and urban/rural differences in cervical carcinoma in Georgia Medicaid recipients. Cancer. 1997;80:231-236.
110. Nasca PC, Burnett WS, Greenwald P, Brennan K, Wolfgang P, Carlton K. Population density as an indicator of urban-rural differences in cancer incidence, upstate New York, 1968-1972. Am J Epidemiol. 1980;112:362-375.
111. Howe HL, Keller JE, Lehnherr M. Relation between population density and cancer incidence, Illinois, 1986-1990. Am J Epidemiol. 1993;138:29-36.
112. Keener B, Jubelirer SJ, German RR, Haddy L. The West Virginia Cancer Registry: historical development and preliminary results. W V Med J. 1995;91:144-146.
113. Miller BE, Flax SD, Arheart K, Photopulos G. The presentation of adenocarcinoma of the uterine cervix. Cancer. 1993;72:1281-1285.
114. Shingleton HM, Bell MC, Fremgen A, et al. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix? Cancer. 1995;76(10 Suppl):1948-1955.
115. Howell E, Chen Y-T, Moradi M, Concato J. Cervical cancer practice patterns and appropriateness of therapy. Obstet Gynecol. 2000;183:407-413.
116. Merrill RM, Merrill AV, Mayer LS. Factors associated with no surgery or radiation therapy for invasive cervical cancer in black and white women. Ethn Dis. 2000;10:248-256.
117. Graham S, Priore RL, Schueller EF, Burnett W. Epidemiology of survival from cancer of the cervix. J Natl Cancer Inst. 1972;49:639-647.
118. Holmquist ND. The delayed diagnosis of invasive carcinoma of the uterine cervix. J La State Med Soc. 1990;142:37-39.
119. Rogot E, Sorlie PD, Johnson NJ, Schmitt C. A Mortality Study of 13 Million Persons by Demographic, Social, and Economic Factors: 1979-1985 Follow-up. US National Longitudinal Mortality Study. Bethesda, Md: National Institutes of Health, National Heart, Lung and Blood Institute; 1992. NIH Publication 92-3297.
120. Mandelblatt JS, Lawrence WF, Womack SM, et al. Benefits and costs of using HPV testing to screen for cervical cancer. JAMA. 2002;287:2372-2381.
121. Yabroff KR, Mandelblatt JS. Potential reduction in incidence and mortality simulation. Reducing Health Disparities in High Cervical Cancer Mortality Regions, The National Cancer Institute; Corpus Christi, Tex.; 2001.
122. Koutsky LA, Ault KA, Wheeler CM, et al. A controlled trial of a human Papillomavirus type 16 vaccine. N Engl J Med. 2002;347:1645-1651.
123. Holschneider CH, Felix JC, Satmary W, Johnson MT, Sandweiss LM, Montz FJ. A single-visit cervical carcinoma prevention program offered at an inner city church: a pilot project. Cancer. 1999;86:2659-2667.